Related Experiment Videos
Nausea and vomiting induced by chemotherapeutic agents
1University of Southern California, Comprehensive Cancer Center, Los Angeles.
Comprehensive Therapy
|December 1, 1991
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Alterations in the pituitary-thyroid and pituitary-adrenal axes--consequences of long-term mifepristone treatment.
Metabolism: clinical and experimental·1997
Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum--DNA adducts.
Annals of oncology : official journal of the European Society for Medical Oncology·1991
Heparin-induced thrombocytopenia and thrombosis.
Comprehensive therapy·2011
Antiplatelet therapy in cardiovascular disease.
Comprehensive therapy·2011
Genetics of cardiovascular disease.
Comprehensive therapy·2011
Septic renal vein thrombosis complicated by septic pulmonary embolism.
Comprehensive therapy·2011
Gout and hyperuricemia.
Comprehensive therapy·2011
Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series.
Comprehensive therapy·2010
Endobiliary Radiofrequency Ablation in Cholangiocarcinoma: Current Evidence and Future Perspectives.
Journal of clinical medicine·2026
PKM2 Inhibitors Induce Autophagic Cell Death Through Suppression of PKM2-Mediated Glycolysis in Cisplatin-Resistant Ovarian Cancer Cells.
International journal of molecular sciences·2026
Current Approaches and Emerging Strategies in the Treatment of Peritoneal Carcinomatosis.
International journal of molecular sciences·2026
A Bioarmored Enzyme Cascade for Sustained Catalysis in Harsh Microenvironments.
ACS applied materials & interfaces·2026